Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants

NCT00038480 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Lopinavir/Ritonavir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]